Company intelligence / Profile preview

Insightec

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Insightec’s MR-guided Focused Ultrasound technology is commercially approved for several indications including essential tremor, Parkinson’s disease, uterine fibroids, and pain palliation of bone metastases. Clinical trials are ongoing in additional oncology and neurological indications. The company has published pivotal trial data in leading journals such as the New England Journal of Medicine.

Therapeutic areas: Women's HealthOncologyNeurology
Modalities: DeviceNon-pharmacological therapy (MR-guided focused ultrasound)
Industry: Therapeutic Medical Devices

Partnerships

Siemens Healthineers (MRI integration)GE Healthcare (founding partner)Academic collaborations with major research hospitals worldwide

Beyond the preview

Go deeper on Insightec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insightec.